Latest Breaking News On - Mark rothera - Page 4 : comparemela.com

Viracta Therapeutics Announces Chief Executive Officer Leadership Succession to Drive the Next Phase of the Company s Strategic Development and Growth

/PRNewswire/ Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced the succession.

United kingdomIvor roystonMark rotheraAshleigh barretoRogerj pomerantzCambridge universityHead of investor relations corporate communicationsAegerion pharmaceuticals incPrnewswire viracta therapeutics incNatural sciencesEuropean institute for business administrationViracta therapeutics incViracta therapeutic boardChief executiveChief executive officerViracta board

Harnessing a Natural Mechanism to Silence Disease

Harnessing a Natural Mechanism to Silence Disease
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

Craig toomanDaniel levineNovartis leqvioGiles campionMark rotheraSilence therapeuticsOrchard therapeuticsShire human genetic therapiesCity rareYounger self

Three Biopharma Companies Bolster Leadership Teams

Silence Therapeutics, Totus Medicines and Poseida Therapeutics all adjust as they welcome new members to their leadership teams.

New jerseyUnited statesRhonda hellumsIain rossBrent warnerpresidentOvid trifanCraig toomanWei chenOnyxpharmaceuticalsand apexigenMark rotheraAvanzar medical incEnzon pharmaceuticals incBristol myers squibbLondon basedsilence therapeutics craig toomanAratana therapeuticsAvanzar medical

Silence Names CFO Its New CEO to Replace Rothera

Silence Names CFO Its New CEO to Replace Rothera
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

Craig toomanRhonda hellumsGiles campionIain rossMark rotheraKalamazoo collegeUniversity of chicagoEnzon pharmaceuticalsGenzyme corporationChief operating officerAratana therapeuticsBefore aratanaAvanzar medical

Silence Therapeutics plc: Silence Therapeutics Appoints Craig Tooman President and Chief Executive Officer

Mark Rothera steps down as President and CEO Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), a leader in the discovery, development and delivery of novel short interfering ribonucleic

Craig toomanRhonda hellumsGiles campionMark rotheraMary conwayIain rossHansoh pharmaKalamazoo collegeMallinckrodt pharmaceuticalsUniversity of texas at san antonioAvanzar medical incAudit committee of curevacExchange commissionDeer oaks mental healthCorporate communicationsUniversity of chicago